Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $.01 per share
-
Shares outstanding
-
92,303,650
-
Total 13F shares
-
91,395,989
-
Share change
-
-1,821,127
-
Total reported value
-
$7,523,912,097
-
Put/Call ratio
-
89%
-
Price per share
-
$82.32
-
Number of holders
-
340
-
Value change
-
-$147,206,889
-
Number of buys
-
175
-
Number of sells
-
144
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $.01 per share (ACHC) as of Q4 2022
As of 31 Dec 2022,
Acadia Healthcare Company, Inc. - Common Stock, par value $.01 per share (ACHC) was held by
340 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,395,989 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, Invesco Ltd., VIKING GLOBAL INVESTORS LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
340
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.